These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34993683)

  • 1. Optimization and Application of an Efficient and Stable Inhalation Exposure System for Rodents.
    Fan Z; Zhou B; Liu Y; Sun W; Fang Y; Lu H; Chen D; Lu K; Wu X; Xiao T; Xie W; Bian Q
    AAPS PharmSciTech; 2022 Jan; 23(1):50. PubMed ID: 34993683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial.
    Hohlfeld JM; Vogel-Claussen J; Biller H; Berliner D; Berschneider K; Tillmann HC; Hiltl S; Bauersachs J; Welte T
    Lancet Respir Med; 2018 May; 6(5):368-378. PubMed ID: 29477448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalation of titanium dioxide (P25) nanoparticles to rats and changes in surfactant protein (SP-D) levels in bronchoalveolar lavage fluid and serum.
    Okada T; Lee BW; Ogami A; Oyabu T; Myojo T
    Nanotoxicology; 2019 Dec; 13(10):1396-1408. PubMed ID: 31512956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of toxicity to triclosan in rats following 28 days of exposure to aerosol inhalation.
    Yang YS; Kwon JT; Shim I; Kim HM; Kim P; Kim JC; Lee K
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):259-68. PubMed ID: 25591546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalation toxicity of 1,6-hexamethylene diisocyanate homopolymer (HDI-IC) aerosol: results of single inhalation exposure studies.
    Pauluhn J
    Toxicol Sci; 2000 Nov; 58(1):173-81. PubMed ID: 11053554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of pulmonary irritant threshold concentrations of hexamethylene-1,6-diisocyanate (HDI) prepolymers by bronchoalveolar lavage in acute rat inhalation studies according to TRGS 430.
    Ma-Hock L; Gamer AO; Deckardt K; Leibold E; van Ravenzwaay B
    Food Chem Toxicol; 2007 Feb; 45(2):237-43. PubMed ID: 17045380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review.
    Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2014; 9():331-8. PubMed ID: 24729699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional contribution of lung, nasal and gastrointestinal absorption to the systemic level following nose-only aerosol exposure in rats: a case study of 3.7- micro m fluorescein aerosols.
    Sakagami M; Kinoshita W; Sakon K; Makino Y
    Arch Toxicol; 2003 Jun; 77(6):321-9. PubMed ID: 12799771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Lung Pharmacokinetic of the Novel PDE4 Inhibitor CHF6001 in Preclinical Models: Evaluation of the PreciseInhale Technology.
    Fioni A; Selg E; Cenacchi V; Acevedo F; Brogin G; Gerde P; Puccini P
    J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):61-70. PubMed ID: 28768120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary responses and recovery following single and repeated inhalation exposure of rats to polymeric methylene diphenyl diisocyanate aerosols.
    Kilgour JD; Rattray NJ; Foster J; Soames A; Hext PM
    J Appl Toxicol; 2002; 22(6):371-85. PubMed ID: 12424741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicological assessment of a prototype e-cigaret device and three flavor formulations: a 90-day inhalation study in rats.
    Werley MS; Kirkpatrick DJ; Oldham MJ; Jerome AM; Langston TB; Lilly PD; Smith DC; Mckinney WJ
    Inhal Toxicol; 2016; 28(1):22-38. PubMed ID: 26787428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary irritant potency of polyisocyanate aerosols in rats: comparative assessment of irritant threshold concentrations by bronchoalveolar lavage.
    Pauluhn J
    J Appl Toxicol; 2004; 24(3):231-47. PubMed ID: 15211618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory peripheral chemosensory irritation, acute and repeated exposure toxicity studies with aerosols of triethylene glycol.
    Ballantyne B; Snellings WM; Norris JC
    J Appl Toxicol; 2006; 26(5):387-96. PubMed ID: 16909429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary effects of ultrafine and fine ammonium salts aerosols in healthy and monocrotaline-treated rats following short-term exposure.
    Cassee FR; Arts JH; Fokkens PH; Spoor SM; Boere AJ; van Bree L; Dormans JA
    Inhal Toxicol; 2002 Dec; 14(12):1215-29. PubMed ID: 12454787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan.
    Horita N; Kaneko T
    Int J Chron Obstruct Pulmon Dis; 2015; 10():813-22. PubMed ID: 25960646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational Study Searching for Synergy between Glycopyrronium and Indacaterol.
    Cazzola M; Calzetta L; Segreti A; Facciolo F; Rogliani P; Matera MG
    COPD; 2015 Apr; 12(2):175-81. PubMed ID: 25222881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats.
    Carvalho SR; Watts AB; Peters JI; Liu S; Hengsawas S; Escotet-Espinoza MS; Williams RO
    Eur J Pharm Biopharm; 2014 Sep; 88(1):136-47. PubMed ID: 24859653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting dual bronchodilator therapy (indacaterol/glycopyrronium) versus nebulized short-acting dual bronchodilator (salbutamol/ipratropium) in chronic obstructive pulmonary disease: A double-blind, randomized, placebo-controlled trial.
    van Geffen WH; Carpaij OA; Westbroek LF; Seigers D; Niemeijer A; Vonk JM; Kerstjens HAM
    Respir Med; 2020 Sep; 171():106064. PubMed ID: 32917359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD.
    Prakash A; Babu KS; Morjaria JB
    Int J Chron Obstruct Pulmon Dis; 2015; 10():111-23. PubMed ID: 25609944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.